Anti-Lymphotoxin alpha antibodies are used for the immunodetection of the protein encoded by the LTA gene. In humans, the canonical protein has a reported length of 205 amino acid residues and a mass of 22.3 kDa. It is known to be a secreted protein. A member of the Tumor necrosis factor protein family, it is a reported cytokine that in its homotrimeric form binds to TNFRSF1A/TNFR1, TNFRSF1B/TNFBR and TNFRSF14/HVEM. Post-translational modifications have been described, including glycosylation. The gene encoding this protein is implicated in Psoriatic arthritis. Other names for this target antigen include TNFB, TNFSF1, TNLG1E, LT-alpha, TNF superfamily, member 1, TNF-beta, tumor necrosis factor beta, and LT. Gene orthologs have been identified in the mouse, rat, bovine, frog and chimpanzee species. Over 60 citations in the literature describe the use of Lymphotoxin alpha antibodies in research. ELISA is a widely used application for these antibodies. In addition, Western Blot is also a common application.